Boston, MA -- (SBWIRE) -- 09/11/2013 -- Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Chartpoppers.com issues news alert on the following stocks:- Patriot Coal Corporation (OTCMKTS:PCXCQ), Nutra Pharma Corp. (OTCMKTS:NPHC), Cellceutix Corp (OTCBB:CTIX), OncoSec Medical Inc (OTCMKTS:ONCS)
Patriot Coal Corporation (OTCMKTS:PCXCQ) moved up 5.39% with the closing price of $0.113. The overall volume in the last trading session was 2.86 million shares. Its fifty two week range was $0.06 -$0.60. The total market capitalization remained $10.48 million.
The stock declined -94.82% in this year and reported the loss of -43.67% in the last 5 days. In its share capital, the company has 92.37 million outstanding shares. Patriot Coal Corporation engages in the mining, preparation, and sale of thermal and metallurgical coal with coal reserves in the Appalachia and the Illinois Basin coal regions in the eastern United States.
For How Long PCXCQ will Fight for Profitability? Read This Trend Analysis report
Nutra Pharma Corp. (OTCMKTS:NPHC) declined -13.92% to end at $0.0167 and its overall volume in the last trading session was 17.02 million shares, versus average trading volume of 8.02 million. It has market cap of $11.99 million while its total outstanding shares are 718.14 million.
The stock gained 33.6% in this year and reported the loss of -27.07% in the last 5 days. The stock 3 month performance stands at 173.77%.Nutra Pharma Corporation, a biotechnology company, engages in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases.
Has NPHC Found The Bottom And Ready To Gain Momentum? Find Out Here
Cellceutix Corp (OTCBB:CTIX) completed latest trade -4.35% lower at $1.98 from prior close of $2.07. It was exchanged between $1.95 – 2.08 with 449,785.00 in overall exchanged numbers of shares. Summarizing after the recent close, its 52 week low price was $0.68 while its 52 week highest price stood at $2.47. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Why Should Investors Buy CTIX After the Recent Fall? Just Go Here and Find Out
OncoSec Medical Inc (OTCMKTS:ONCS) during the previous trading period, showed a negative activity of -8.86%. Currently, the company has a market capital of $28.20 million dollars. The stock’s final trade was made at $0.319, while it had started its day-trade at $0.35. In the past 52-week period, the stock has not gone below $0.18 and traded at maximum level of $0.49. OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
Will ONCS Get Buyers Even After The Recent Rally? Find Out Here
Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks!
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)